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Diversity in the CDR3 Region of VH
Is Sufficient for Most Antibody
Specificities
1990; Davies and Cohen, 1996; Garcia et al., 1999). How-
ever, despite the broad interface seen in the crystal
structures, sequence diversity in antigen receptors is
not evenly distributed among all six CDRs but is highly
concentrated in one (in the cases of antibodies and gd
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TCRs) or two (in the case of ab TCRs) CDR3s (Davis
and Bjorkman, 1988; Davis and Chien, 1999). Although
Summary the skewing of diversity toward CDR3s in ab TCRs is
understandable because these amino acid residues
All rearranging antigen receptor genes have one or mainly recognize the antigenic peptide while other CDRs
two highly diverse complementarity determining re- primarily interact with MHC (Jorgensen et al., 1992; Gar-
gions (CDRs) among the six that typically form the boczi et al., 1996; Garcia et al., 1996; Sant'Angelo et al.,
ligand binding surface. We report here that, in the case 1996; Ding et al., 1998; Reinherz et al., 1999), there has
of antibodies, diversity at one of these regions, CDR3 been no explanation for such a phenomenon in antibod-
of the VH domain, is sufficient to permit otherwise iden- ies and gd TCRs. Even more puzzling is the finding that
tical IgM molecules to distinguish between a variety in antibodies, both CDR1 and CDR2 of the heavy chains
of hapten and protein antigens. Furthermore, we find and all CDRs of the light chains have only a few ªcanoni-
that somatic mutation can allow such antibodies to calº conformations, and only the heavy chain CDR3 loop
achieve surprisingly high affinities. These results are has a wide range of variations in both length and shape
consistent with a model in which the highly diverse (Chothia and Lesk, 1987; Chothia et al., 1989). Such
CDR3 loops are the key determinant of specificity in canonical CDR loop shapes have also been seen in ab
antigen recognition in both T cell receptors (TCR) and TCR crystal structures (CDR2 of a and b particularly,
antibodies, whereas the germline-encoded CDR1 and but not in CDR3a or CDR3b) (Garcia et al., 1999), al-
CDR2 sequences are much more cross-reactive. though some of this uniformity may relate to MHC bind-
ing requirements. The skewing of diversity in all antigen
Introduction receptor molecules has led to the suggestion that the
highly diverse CDR3 sequences are the principal deter-
During lymphocyte development, a large repertoire of minant of specificity in antigen recognition, at least in
heterodimeric antigen receptors, both antibodies and
the primary repertoire (Davis et al., 1997, 1998).
TCRs, are generated by a variety of mechanisms (Tone-
To further understand the molecular basis of antigen
gawa, 1983; Davis and Bjorkman, 1988). In antibodies,
receptor specificity, we have constrained mice to use
the binding site for antigens is formed by six CDRs that
a single VH gene but full CDR3 diversity to generate theirloop out from the V region backbone formed by two
B cell repertoire. We challenged such mice with a varietysheets of b-pleated strands (reviewed in Davies et al.,
of protein and hapten antigens and monitored the devel-1990). Great importance has been attached to the germ-
opment of primary and memory immune responses. Weline V gene repertoire for the development of effective
find that antigen-specific IgM molecules isolated fromimmune responses, as most of the CDRs are encoded
primary response of these mice can differ only in theby the germline sequences (with the exception of CDR3
CDR3 of the VH domain; furthermore, we find that so-of the heavy chain). It has been postulated that the V
matic mutation can allow such antibodies to achieveregion genes are selectively retained in the germline
surprisingly high affinities upon rechallenge with proteinduring evolution because of their capacity to accommo-
antigens. The only antigens that seem generally unabledate different antigens, especially pathogens (e.g., Cohn
to be accommodated by an arbitrarily chosen VH areet al., 1980; Rajewsky et al., 1987).
bacterial polysaccharides. These results indicate thatRecent structural analyses show that in ab TCRs,
an extensive V (both VH and VL) gene repertoire is notamino acids at positions equivalent to the CDRs in anti-
necessary for the production of specific antibodies tobodies also form the principal contacts between TCRs
most antigens, and that the VH CDR3 plays a very differ-and their peptide/MHC ligands (Garboczi et al., 1996;
ent role in the makeup of the antibody binding site thanGarcia et al., 1996; Ding et al., 1998; Reinherz et al.,
the germline-encoded CDR1 and CDR2 sequences.1999). While no complete structure of a gd TCR in com-
These results suggest that the purpose of the highlyplex with its ligand is currently available, a number of
diverse CDR3 region of all antigen receptors, both TCRsstudies indicate that gd TCRs recognize antigens in an
and antibodies, is to determine antigen specificity.antibody-like manner (reviewed in Chien et al., 1996; see
also Li et al., 1998). The binding interfaces between
antigen receptor molecules and their ligands are gener-
ally large (over 1500 AÊ 2) and 10±30 side chains from each Results
side make close contacts (reviewed in Davies et al.,
Experimental System
In order to characterize the antibody responses of an³ To whom correspondence should be addressed (e-mail: mdavis@
cmgm.stanford.edu). organism with a very limited V region repertoire but full
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mice were bred onto an IgH2/2 Igk2/2 background (Chen
et al., 1993a, 1993b). With this genotype (HC11/0 IgH2/2
Igk2/2), the only functional immunoglobulin that can be
produced would combine the single VH5±51 with one of
the three l light chain V regions (Vl1, Vl2, or Vlx; Figure
1B) from the mouse. Flow cytometry analysis revealed
that the HC1 transgene partially rescues the B cell com-
partment of an IgH2/2 Igk2/2 mouse, although B cell num-
bers are extremely low (5%±10% normal; data not
Figure 1. Physical Map of the Transgenic Heavy Chain Minilocus shown). Serum analysis shows that levels of IgM and
HC1 and the Endogenous Mouse l Light Chain Locus IgG1 range from 60 to 300 mg/ml (5%±10% normal) and
Drawings are schematic and not to scale. c denotes pseudogenes. 0.3 to 5.0 mg/ml (0.1%±1% normal), respectively, in these
V, variable gene segment; D, diversity segment; J, joining segment; mice (data not shown).
C, constant region gene; S, switch region; E, enhancer.
Antigen-Specific Development of Immune Responses
in the HC11/0 IgH2/2 Igk2/2 MiceCDR3 diversity, we utilize a previously described trans-
gene, HC1, which contains one functional human VH To test whether the B cell repertoire with diversity only
in VH CDR3 is effective, we immunized the HC11/0 IgH2/2gene segment (VH5±51), ten functional D segments, six
JH segments, and the Cm and Cg1 constant regions (Fig- Igk2/2 mice with a variety of protein antigens: keyhole
limpet hemocyanin (KLH), hen egg-white lysozyme (HEL),ure 1A; Taylor et al., 1992, 1994). The HC1 transgenic
Figure 2. Antigen-Specific Development of
IgM and IgG Responses in the HC11/0 IgH2/2
Igk2/2 Mice
The HC11/0 IgH2/2 Igk2/2 mice were immu-
nized with KLH (A), OVA (B), HEL (C), DNP-
KLH (D), phOx-CSA (E), or PC-KLH (F) on
indicated days. Serum samples were col-
lected 7 days after each injection and diluted
1:10±1:250 into microtiter wells coated with
KLH or HEL (A), OVA or KLH (B), HEL or KLH
(C), DNP-BSA or PC-BSA (D), phOx-BSA or
KLH (E), or PC-BSA or DNP-BSA (F). Antigen-
bound IgM or IgG was detected as described
in the Experimental Procedures. At least three
mice were tested for each antigen and for
clarity, results from a representative mouse
were shown. Variations among individual
mice were within a 5-fold range.
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Figure 3. Sequence Analysis of Monoclonal Anti-DNP, Anti-OVA, Anti-KLH, and Anti-HEL IgM Antibodies Originated from the HC11/0 IgH2/2
Igk2/2 Mice
The cDNA encoding monoclonal antibodies against various antigens was synthesized and amplified by RT-PCR, cloned, and sequenced.
Shown are the deduced amino acid sequences of both heavy (A) and light (B) chains of various monoclonal antibodies. The top line in (A) is
the germline VH5±51 sequence; the top two lines in (B) are the germline Vl1 and Vl2 sequences. Dashes in the sequences indicate identity to
the top line. The CDRs in both heavy and light chain are underlined. In VH CDR3, amino acid residues encoded by the J segment are separated
by spaces from those encoded by the D segment (in bold) and N nucleotides. D segment assignments are based on at least six nucleotides
of homology; amino acid residues not accounted for by D are presumably encoded by the N nucleotides. All monoclonal antibodies shown
here are of IgM isotype. Some of these hybridomas (e.g., DNP-8, DNP-11, KLH-1, KLH-3, and OVA-2) were isolated twice from the same
fusion.
chicken ovalbumin (OVA), cholera toxin B subunit (CTB), more detail, we immunized HC11/0 IgH2/2 Igk2/2 mice with
antigens and isolated hybridoma cell lines producingas well as haptens: 2,4-dinitrophenyl (DNP, conjugated
to KLH), 2-phenyl-4-ethoxymethylene-5-oxazolone (phOx, antigen-specific IgM antibodies. Animals were immu-
nized only once to minimize somatic hypermutation.conjugated to chicken serum albumin, CSA), and phos-
phorylcholine (PC, conjugated to KLH). Figure 2 shows Complementary DNA (cDNA) from both heavy and light
chain mRNA of these antibodies was synthesized, ampli-the results of enzyme-linked immunosorbent assay
(ELISA) of some of these responses. As typical of normal fied by polymerase chain reaction (PCR), and then
cloned and sequenced. All the hybridomas character-immune responses, IgM antibodies appeared first, fol-
lowed by IgG. All HC1 mice examined responded to all ized used both VH5±51 and Cm from the HC1 transgene
in their heavy chain and used either Vl1±Jl1 or Vl2±Jl2antigens tested, except the pigeon cytochrome c (PCC)
protein, to which only three out of nine mice were able in their light chain (with the exception of hybridoma
HEL-2, which appears to use Vl1±Jl2 in its light chain;to make a detectable response (data not shown), sug-
gesting that B cell clones with this specificity are very Figure 3 and data not shown). No Vlx usage was ob-
served.rare in these mice.
A comparison of the anti-DNP, anti-KLH, anti-OVA,
and anti-HEL IgM sequences shows that most expressSequence Analysis of Antigen-Specific Antibodies
Derived from the HC11/0 IgH2/2 Igk2/2 Mice the VH5±51 gene segment in its germline form and thus
differ only in the CDR3 region of the heavy chain. InIt has been previously reported that in mice with a fixed
VDJH rearrangement, V gene replacement and somatic addition, there are two large sets of hybridomas that
express identical light chains as well. The first set in-hypermutation can generate a significant level of func-
tional diversity in the primary repertoire (Cascalho et cludes DNP-6, DNP-7, DNP-8, DNP-11, DNP-12, KLH-5,
OVA-1, OVA-2, and OVA-4; and the second includesal., 1996; LoÂ pez-MacõÂas et al., 1999). It was therefore
possible that secondary rearrangements and/or somatic DNP-10, KLH-6, OVA-6, and HEL-1 (Figure 3). ELISA
assays on all of these antibodies confirmed that theymutations could contribute to the antibody responses
seen in the HC11/0 IgH2/2 Igk2/2mice. To control for this, only bind the antigen they were raised against, consis-
tent with the whole serum analysis shown in Figure 2as well as to characterize the responding antibodies in
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Figure 4. Sequence Analysis of Monoclonal Anti-OVA and Anti-HEL IgG1 Antibodies Originated from the HC11/0 IgH2/2 Igk2/2 Mice
The cDNA encoding monoclonal IgG1 antibodies against OVA (OVA-7) and HEL (HEL-3) was synthesized, amplified by RT-PCR, cloned, and
sequenced. Shown are the deduced amino acid sequences. Similar as in Figure 3, D segment assignments are based on at least six nucleotides
of homology.
(data not shown). These results show that diversity in whether such mice can produce high-affinity antibodies.
We pursued this question both by generating mono-the CDR3 region of VH alone is sufficient to obtain highly
specific IgM antibodies to these antigens. clonal IgG antibodies through hyperimmunization and
by purifying polyclonal IgG antibodies from antisera. WeAmong the DNP-specific hybridomas isolated, two
sequences (DNP-8 and DNP-11) were seen twice; in obtained two IgG1 monoclonal antibodies, one specific
for HEL (HEL-3) and the other for OVA (OVA-7). Bothaddition, DNP-6 and DNP-11 are different at only one
position (isoleucine versus alanine) in VH CDR3. Fur- monoclonal antibodies used the VH5±51±Cg1 in the
heavy chain and Vl1±Jl1±Cl1 in the light chain. Boththermore, the junctional diversity in the heavy chain is
restricted. For example, all but one hybridomas had HEL-3 and OVA-7 antibodies also exhibit evidence of
somatic hypermutation in both the g1 and l chains withidentical CDR3 length, utilized JH2 gene segment, and
expressed glutamine at position 95 (the first amino acid most of the mutations being located in the CDR regions
(Figure 4), as is typical.in the junctional region); in the light chains, all but one
had leucine at position 96 (the first amino acid in the We then employed surface plasmon resonance (SPR)
technique (Malmqvist, 1993) to measure the affinity ofjunctional region), even though tryptophane is encoded
at that position in the germline Jl1. In the hybridomas these antibodies. We immobilized the HEL-3 antibody
on the biosensor chip and passed different concentra-specific for protein antigens, there were identical re-
peats as well: for example, sequences represented by tions of HEL over the immobilized antibody (Figure 5A).
Fitting of the binding curves gives an association rateKLH-1, KLH-3, and OVA-2 were all isolated twice. Also,
OVA-1 and OVA-2 are different only at position 96 in the of 9.8 3 106 M21 s21 and a dissociation rate of 2.5 3
1024 s21 at 258C. These values give a KD of 2.55 3 10211heavy chain, with arginine in OVA-1 and lysine in OVA-2;
both arginine and lysine residues are positively charged. M, or 25.5 pM, equivalent to the highest affinity anti-
HEL antibodies known (Davies and Cohen, 1996). For
unknown reasons, immobilization of OVA-7 on a biosen-High-Affinity IgG1 Antibodies for Protein Antigens
from the HC11/0 IgH2/2 Igk2/2 Mice sor chip leads to its inactivation (data not shown); thus,
we immobilized OVA on the biosensor chip and allowedHaving established that the HC11/0 IgH2/2 Igk2/2 mice
are capable of mounting highly specific antibody re- OVA-7 to bind to the immobilized ligand (Figure 5B).
While accurate fitting of the bivalent IgG binding is notsponses to most, if not all, of the antigens, we asked
Figure 5. High-Affinity IgG1 Antibodies De-
rived from the HC11/0 IgH2/2 Igk2/2 Mice
(A) HEL was passed over the immobilized
monoclonal HEL-3 antibody (250 RU) at con-
centration of 2.5 (triangles), 5.0 (diamonds),
10 (squares), and 20 (circles) nM at a flow rate
of 100 ml/min.
(B) OVA-7 (20 mg/ml) was passed over immo-
bilized OVA (1000 RU, closed circles) or
empty surface (open circles).
(C±D) HC11/0 IgH2/2 Igk2/2 mice were immu-
nized with HEL (C) or OVA (D). Antiserum sam-
ples were collected after fourth, fifth, and
sixth injection and pooled. Total IgG1 was
purified from preimmune (open circles) or an-
tiserum (closed circles) with affinity column
using goat anti-human IgG1 (Fc specific) anti-
body conjugated to agarose beads, and
passed over HEL (C) or OVA (D) coupled to
the CM5 sensor chip at a concentration of 25
mg/ml.
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possible, we did find that OVA-7 dissociates very slowly:
the apparent dissociation rate is z5.0 3 1024 s21. As
bivalent antibodies have dissociation rates that are ap-
proximately 10-fold slower than their monovalent Fab
fragments (Mason and Williams, 1986), the estimated
bona fide dissociation rate constant of OVA-7 is approxi-
mately 5.0 3 1023 s21. Given a typical association rate
of 0.525 3 106 M21 s21 for protein±protein interactions
(Northrup and Erickson, 1992), the KD of OVA-7 would
be in the 1±10 nM range, comparable with monoclonal
antibodies isolated from normal mice.
Total IgG1 antibodies from the HC11/0 IgH2/2 Igk2/2
mice immunized with HEL, OVA, or KLH were also used
in SPR analysis (Figures 5C and 5D and data not shown).
Again, we found that polyclonal IgG1 antibodies purified
from the HC11/0 IgH2/2 Igk2/2 mice bind their cognate
antigen fairly tightly, with an apparent dissociation rate
of z1 3 1024 s21 (Figures 5C and 5D). Thus, the average
KD of these antibodies would also be in the 0.2±2 nM
range, assuming a typical association rate of 0.5±5 3
106 M21 s21.
Taken together, the antigen binding data from both
HEL-3 and OVA-7 monoclonals and the polyclonal anti-
sera shows that somatic mutation can allow antibodies
from the HC11/0 IgH2/2 Igk2/2 mice to achieve very high
affinities against at least protein antigens, comparable
to mice with a full V region repertoire.
Failure of the HC11/0 IgH2/2 Igk2/2 Mice to Respond
to Bacterial Polysaccharides
Figure 6. HC11/0 IgH2/2 Igk2/2 Mice Mount IgM Response to TNP-If one VH gene is able to accommodate most or all of
Ficoll but Not to DEX or Levanthe antigens, why are there so many different VH genes
Mice with indicated genotypes were injected intravenously with 10in most vertebrate genomes? It is currently thought that
mg DEX (A and B) or TNP-Ficoll (E and F), or intraperitoneally withthe T cell±independent IgM response to bacterial poly-
50 mg levan (C and D) on day 0, 14, and 28. Serum samples weresaccharides provides an important protection to the collected 7 days after each injection and diluted 1:10±1:250 into
host during infections (Janeway and Travers, 1997). If microtiter wells coated with DEX (A and B), levan (C and D), or TNP-
this defense relies on a large V region repertoire, as BSA (E and F). Antigen-binding human or mouse antibodies (IgM
and IgG) were detected with alkaline phosphatase conjugated goatpreviously suggested (Cohn et al., 1980; Rajewsky et
anti-human or goat anti-mouse secondary antibodies.al., 1987), the HC11/0 IgH2/2 Igk2/2 mice may not be able
to mount an antibody response to some bacterial carbo-
hydrate antigens. Therefore, we injected five HC11/0
Vk chain(s). To test this possibility, we reintroduced aIgH2/2 Igk2/2 and five C57BL/6 (B6) mice with dextran
functional Igk locus into the mutant mice, but the re-B512 (DEX) from Leuconostoc mesenteroides, a near-
sulting animals (HC11/0 IgH2/2 Igk1/2) were still unablelinear glucose polymer with 96% a(1!6) linkages, and
to respond to DEX (Figure 6A). In addition, we also immu-followed the immune response by ELISA. DEX-specific
nized Igk2/2 mice (with a normal VH gene repertoire) withIgM was detected in every B6 mice after the first injection
this antigen, and they were also unable to respond (Fig-(Figure 6B); however, no IgM response was observed
ure 6B).in any of the HC11/0 IgH2/2 Igk2/2 mice even after three
The observation that (IgH1/1) Igk2/2, HC11/0 IgH2/2injections of DEX (Figure 6A). The HC11/0 IgH2/2 Igk2/2
Igk1/2, and HC11/0 IgH2/2 Igk2/2 mice all failed to respondmice also failed to respond to levan, a branched fructose
to DEX indicates that neither VH5±51 nor any of the Vlpolymer from Erwinia herbicola (Figures 6C and 6D). In
genes can be utilized to accommodate this antigen.contrast, the HC11/0 IgH2/2 Igk2/2 (as well as B6) mice
However, it cannot be ruled out that a very low frequencyresponded to other T-independent antigen, for example,
of DEX-specific B cells were still present in these mice,2,4,6-trinitrophenyl (TNP)-Ficoll (Figures 6E and 6F).
but the few precursor B cells were overwhelmed by anThus, the lack of responsiveness to the two polysaccha-
excess of antigen (i.e., high zone tolerance was induced)ride antigens in the HC11/0 IgH2/2 Igk2/2 mice is probably
(Howard et al., 1975; Fernandez and MoÈ ller, 1977).not due to lack of T cell help. Since all anti-DEX mono-
clonal antibodies reported use the k light chain (Akolkar
et al., 1987; Wang et al., 1990), and it has been shown Discussion
that the Vk domains do provide antigenic contacts in
these antibodies (Wallick et al., 1989), it is possible that It has been known for some time that in both B and T
cell recognition, some epitopes show restricted V genethe failure of the HC11/0 IgH2/2 Igk2/2 mice to respond
to DEX could be solely due to the lack of the appropriate usage. For example, very limited VH and VL genes are
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used in immune responses of inbred mice to many hap- with the findings that murine B cells that have a re-
arranged heavy chain immunoglobulin gene in the germ-ten, polysaccharide, and even protein antigens, includ-
ing p-azophenylarsonate (Pawlak et al., 1973; MaÈ kelaÈ line always change the CDR3 sequence and often the
VH as well when they deviate from the original antigenet al., 1976; Manser, 1990), phenyloxazolone (MaÈ kelaÈ et
al., 1978; Kaartinen et al., 1983; Berek and Milstein, reactivity (Cascalho et al., 1996; LoÂ pez-MacõÂas et al.,
1999). Our data may explain the long-standing puzzle1987), (4-hydroxy-3-nitrophenyl)acetyl (NP) (Imanishi
and MaÈ kelaÈ , 1974, 1975; Blier and Bothwell, 1988), DNP of ªcanonicalº CDR structures in antibodies (Chothia
and Lesk, 1987; Chothia et al., 1989). We would suggest(Dzierzak et al., 1980, 1985), phosphorylcholine (Potter
and Lieberman, 1970; Sher and Cohn, 1972; Barstad et that uniform CDR shapes are important for the stability
of a binding site, with the exception of VH CDR3, whichal., 1974; Crews et al., 1981), phosphatidylcholine (Seidl
et al., 1997), dextran (Blomberg et al., 1972; Riblet et has to ªfitº the antigen surface much more precisely.
These results are also reminiscent of the case of humanal., 1975; Wang et al., 1990), galactan (Mushinski and
Potter, 1978), Staphylococcal nuclease (Fathman et al., growth hormone and its receptor, where structural anal-
ysis shows that about 30 side chains from each protein1977), and influenza hemagglutinin (McKean et al., 1984;
Clarke et al., 1985). T cell recognition of peptide/MHC are in close contact but only a fraction of those residues
have any contribution to the binding affinity and onlycomplexes is often (but not always) fairly restricted with
respect to V gene usage (e.g., Hedrick et al., 1988). two account for more than three-quarters of the free
energy (Wells, 1996).However, it is not clear whether the preferred V gene
segment(s) are absolutely required for such epitopes or Another interesting issue raised by the data presented
here is the role of somatic mutation in producing higher-are merely the result of extensive clonal expansion
where a slight advantage in binding would allow the affinity antibodies upon rechallenge with antigen. Our
data shows that, at least for protein antigens, having anmost optimal VHVL combination to predominate. In the
current study, we find that mice having only one func- arbitrarily chosen human VH and one of two mouse l
chains as a germline repertoire is no barrier to generat-tional VH and (effectively) two VL gene segments are able
to mount highly specific antibody responses to most ing very high-affinity IgG antibodies. This finding is con-
sistent with work on the chicken immunoglobulin genes,antigens. It thus seems likely that the restricted V gene
usage observed in most immune responses represents where only a single functional VH and VL are utilized, but
goes beyond this in two important respects. One is thatthe consequence of antigen-driven clonal expansion of
kinetically favorable antigen receptor clone(s). chickens have somatically mutated antibodies prior to
immunization (Weill and Reynaud, 1987; McCormack etIn the HC11/0 IgH2/2 Igk2/2 mice, we find a remarkable
restriction in VH CDR3 diversity with respect to both al., 1991), thus allowing the argument that this sequence
diversification takes the place of a large V region reper-length and amino acid composition in the primary im-
mune response to both hapten and protein antigens. In toire. Second, the germline VH and Vk genes utilized
have been selected over many millions of years for theirthe IgM antibodies, there are many identical or very
similar sequences. A restrictive pattern of VH CDR3 compatibility with many different antigens and thus they
may represent the most polyfunctional VHVL pair. In ourwould normally be interpreted to mean antigen-driven
clonal expansion; however, considering the low effi- system, we have chosen our VHVL pair at random, sug-
gesting that all or most such pairs are capable of bindingciency of cell fusion, the isolation of identical repeats
suggests that certain antibody specificities could be a large number of different antigens, given a single,
diverse VH CDR3. This indicates that an antibody bindingspecifically expanded even prior to immunization (Ra-
jewsky et al., 1987). It is not clear at present whether site excluding VH CDR3 is exceptionally cross-reactive,
at least until acted on by somatic mutation (Patten etthe expansion of a particular specificity occurs as a
result of preferred V(D)J rearrangement event or is the al., 1996; Wedemayer et al., 1997). This interpretation
is consistent with the observations that the residuesresult of some type of selection.
Our results also indicate that the antigen binding site characteristic of antibody binding sites have an unusu-
ally high proportion of asparagines, lysines, and aro-of nonsomatically mutated antibodies is not uniformly
specific but instead consists of one highly diverse CDR matic amino acids, more typical of the interior of a globu-
lar protein than to its surface and capable of making aloop (VH CDR3) and at least four ªgenericº antigen bind-
ing regions (CDRs 112). Even the somewhat diverse VL wide variety of different contacts (Kabat et al., 1977;
Janin and Chothia, 1990; Padlan, 1990; Mian et al., 1991).CDR3 region seems to play a very minor role. Using a
phage display library, Winter and colleagues previously It also has some similarities to the proposal of Pauling
and others that a single antibody molecule could foldshowed that a range of hapten and protein binding activ-
ities could be isolated from a repertoire of antibodies around different antigens in different ways to achieve
specificity (Pauling, 1940).comprising 50 human VH gene segments in combination
with a fixed light chain (Hoogenboom and Winter, 1992; The data presented here, as well as previous work,
strongly suggest that the purpose of highly diverseNissim et al., 1994). That VH CDR3 might play a dominant
role in antigen binding was also suggested by earlier CDR3 regions in all antigen receptors is to provide anti-
gen specificity. It supports our earlier speculationsstudies showing that a heavy chain alone or even single
VH domains can bind antigens with a comparable affinity (Davis et al., 1997, 1998) but is not consistent with the
Protecton model of Cohn and colleagues, which arguesas the intact antibody (Ward et al., 1989; NoeÈ l et al.,
1996). In addition, it has been found that randomly muta- that the primary antibody repertoire is solely defined
by germline VH and VL gene sequences (i.e., CDR1 andgenizing the VH CDR3 of an anti-tetanus toxin antibody
enables the isolation of a new specificity (i.e., for fluores- CDR2) and that CDR3 is not important in the initial deter-
mination of antibody specificity (Langman and Cohn,cein) (Barbas et al., 1992). Our results are also consistent
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diluted serum, and antigen-bound human or mouse IgM or IgG was1987; Cohn and Langman, 1990). The Protecton model
detected as above with alkaline phosphatase conjugated polyclonalalso argues that in the primary antibody repertoire, each
goat anti-human (or mouse) IgM or goat anti-human (or mouse) IgGspecificity is expressed by a large number of B cells.
antibodies. To generate antigen-specific hybridomas, splenocytes
Our data support the notion that certain antibody speci- were isolated from mice immunized with KLH, OVA, HEL, or DNP-
ficities may be relatively abundant prior to antigen stimu- KLH, and fused with the nonsecreting myeloma P3X63-Ag8.653 cells
using standard procedures (Harlow and Lane, 1988). Hybridomaslation in these mice. Thus, it would be interesting to test
were subcloned by limiting dilution after being shown to producewhether some CDR3 sequences are expressed at higher
antigen-specific IgM or IgG1 antibody in ELISA.frequencies than others in the preimmune repertoire in
the mice analyzed here and in wild-type animals.
RT-PCR and Sequence AnalysisThe only deficit we have detected in the immune reper-
Total RNA was isolated from B cell hybridomas with the RNeasytoire of mice with limited V gene(s) so far is in their
mini kit (Qiagen). cDNA was synthesized using oligo (dpT)12±18 (Col-inability to respond to bacterial polysaccharide anti- laborative Biomedical Products, Bedford, MA) and SUPERSCRIPT
gens. Interestingly, chickens are unable to mount robust II RNase H2 reverse transcriptase (GIBCO-BRL, Gaithersburg, MD)
antibody responses to carbohydrates as well (Jeurissen and amplified by PCR with TaqPlus Precision PCR system (Stra-
tagene, La Jolla, CA). The primer pairs used in PCR were as follow:et al., 1998), although this point is controversial (Gran-
VH5±51.L (59-cctcgccctcctcctagctattc-39) and Cm.1 (59-gaaggaagtcfors et al., 1982; Jalkanen et al., 1983). If the failure to
ctgtgcgaggcag-39) (for m chains); VH5±51.L9 (59-ccatcctcgccctcctcrespond to bacterial polysaccharides is due to the lack
cta-39) and Cg1.1 (59-cgcctgagttccacgacacc-39) (for g1 chains); andof appropriate VH/VL pair(s) to accommodate these mole- Vl1,2.L (59-tcacttatactctctctcctg-39) and Cl1,2,3.1 (59-ggaaggtg
cules, the HC11/0 IgH2/2 Igk2/2 mice may have difficulties gaaaca[t/c/g]ggtga-39) (for l chains). Amplified cDNA was cloned
in clearing bacterial infections. The system described into pGEM-T Easy vector (Promega, Madison, WI) and sequenced
with the Taq Dye Deoxy Terminator Cycle Sequencing kit (Appliedhere will provide an experimental test for the idea that
Biosystems, Foster City, CA) on an Applied Biosystems 373A DNAunique VH/VL pairs could be selected by pathogens dur-
Sequencer (PAN Facility, Stanford University).ing evolution and then fixed in the germline (Langman
and Cohn, 1987; Cohn and Langman, 1990).
Antibody Purification and Affinity Measurements
IgG1 antibody was purified from mouse serum or hybridoma super-Experimental Procedures
natant by affinity column using goat anti-human IgG1 (Fc specific)
antibodies conjugated to agarose beads (Sigma) according to stan-Mice
dard procedures (Harlow and Lane, 1988), and exchanged into PBSB6 mice were originally obtained from the Jackson Laboratory (Bar
using Centricon-30 (Amicon, Inc., Beverly, MA). Antigen or antibodyHarbor, ME) and bred at our Animal Research Facility at Stanford
was immobilized to the BIAcore CM5 chip (Pharmacia Biosensor)University. Mice transgenic for the human heavy chain minilocus
by standard amine chemistry. Binding of antibody to immobilized
HC1 were previously described (Taylor et al., 1992, 1994). Mice
antigen was performed in PBS with 20 ml injections at a flow ratecontaining targeted deletions of the JH region or the Jk±Ck region of 5 ml/min. Binding of HEL (freshly purified on a Superdex-75 sizewere also described and are referred to in this paper as IgH2/2 or
exclusion column [Pharmacia]) to immobilized antibody was carried
Igk2/2 (Chen et al., 1993a, 1993b). The HC1 transgenic mice were
out in PBS with 150 ml injections of protein at a flow rate of 100 ml/bred onto the IgH2/2 Igk2/2 background. Details of mouse breeding
min. Regeneration of the biosensor surface was carried out withand screening will be furnished upon request.
two 20 s pulse of 0.1 M glycine (pH 2.5) at a flow rate of 15 ml/min.
All SPR measurements were performed at 258C on BIAcore 1000.
Reagents The association and/or dissociation phases of antigen-antibody in-
BSA, CTB, CSA, DEX (MW 500,000), HEL, KLH, levan, OVA, PCC, teraction were fit with the single-site binding model of BIAEvaluation
and phOx were purchased from Sigma (St. Louis, MO). DNP-KLH 3.0 (Pharmacia Biosensor).
and DNP-BSA were from Calbiochem (La Jolla, CA). TNP-Ficoll and
TNP-BSA were from Biosearch Technologies, Inc. (Novato, CA).
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